While sifting through the bacterial genome of salmonella, Cornell food scientists discovered mcr-9, a new, stealthy jumping gene so diabolical and robust that it resists one of the world’s few last-resort antibiotics.
Doctors deploy the antibiotic colistin when all other infection-fighting options are exhausted. But resistance to colistin has emerged around the globe, threatening its efficacy.
“This last-resort antibiotic has been designated a highest-priority antibiotic by the United Nations’ World Health Organization, and the mcr-9 gene causes bacteria to resist it,” said Martin Wiedmann, Cornell’s Gellert Family Professor in Food Safety and senior author on the study published May 7 in the journal Mbio. “In treatments, if colistin does not work, it literally could mean death for patients. If colistin resistance spreads, a lot of people will die.”
Co-lead author Laura Carroll, a computational biologist and Cornell doctoral candidate, found mcr-9 in the genome of a strain of foodborne pathogen salmonella.
Because the DNA sequence of the mcr-9 gene was similar to other genes that could cause bacteria to resist colistin, she suspected that the salmonella strain which carried mcr-9 was colistin-resistant. To her surprise, the salmonellastrain failed to show colistin resistance.
Knowing that the mcr-9 gene could jump to other bacteria or organisms, her colleague, senior research associate Ahmed Gaballa, a microbiologist and co-lead author, inserted the gene into a nonpathogenic strain of the bacterium E. coli. Gaballa was able to “turn on” mcr-9, making the E. coli strain resistant to colistin. That showed Carroll was initially correct.
“When we originally tested the salmonella isolate and found that it wasn’t resistant to colistin, we were perplexed,” Carroll said. “But when Ahmed cloned it into an E. coli host, he was able to find that the gene could confer resistance to colistin.”
Mcr-9 is the latest in this new series of “mobilized colistin-resistance” genes – originally discovered in 2015. The National Center for Biotechnology Information, part of the National Institutes of Health, has added details about this new gene to its database. Medical professionals and others can now use this information to identify mcr-9 in bacteria isolated from food products and people.
Details about mcr-9 in national and international databases enable scientists to develop better prevention and treatment, explained Wiedmann. “This improves our ability to get an early warning,” he said.
Bacteria isolated from food products can now be tested for mcr-9, and patients can be screened for colistin-resistant bacteria which possess mcr-9. “If you go to a hospital and this gene is floating around, that can be trouble. The gene is moveable. It jumps,” Wiedmann said.
“In a hospital setting, being able to screen a patient for resistance allows doctors and nurses to isolate the patient and maintain biosecurity.”
Wiedmann pointed out that while his lab is dedicated to food safety, the collaboration of scientists from different fields made the discovery possible. “In this age of complicated problems, we need the computational bioinformatics approach to find solutions,” he said. “Standard biological research and standard tests would not necessarily have found this gene.”
Carroll added: “It takes a village of a computational biologist, a microbiologist and a molecular biologist to make this sort of scientific discovery happen.”
The Latest on: Last-resort antibiotics
via Google News
The Latest on: Last-resort antibiotics
- Superbugs resistant to last-resort drugs infecting the Yamuna, says studyon October 4, 2019 at 3:10 am
New Delhi: The Yamuna is teeming with bacterial communities resistant to not only commonly used antibiotics but also last-resort bacterial infection drugs, a study has found. Scientists from the ...
- Superbugs not sci-fi anymoreon October 3, 2019 at 3:30 pm
This gene was first noticed in patients from India. It renders bacteria resistant to carbapenems, a category of strong antibiotics that are commonly referred to as drugs of last resort. In theory, ...
- Drug-resistant infections: the science is on track, but the economics need fixingon October 1, 2019 at 2:41 am
We already treat many with our last resort antibiotics, and now we see resistance emerging to these." The obvious solution is to come up with new drugs, but antibiotics are so unprofitable that big ...
- A new class of antibiotic candidates for fighting against superbugson September 24, 2019 at 6:57 am
much better than commonly used antibiotics, including vancomycin with the MIC of 1 μg/mL which is labeled as the "last resort" antibiotic drug in the United States. Further preclinical studies on the ...
- Long courses of antibiotics harm infant gut, promote resistanceon September 23, 2019 at 6:07 am
These antibiotics included ciprofloxacin and chloramphenicol, as well as last-resort antibiotics for multidrug-resistant organisms like tigecycline and colistin. “From a clinical standpoint, our ...
- Farm Animals Are the Next Big Antibiotic Resistance Threaton September 19, 2019 at 7:09 am
One example: As many drugs have lost their effectiveness, medicine has reached further back on the shelf, to antibiotics that went out of favor years ago. About a decade ago, doctors needing a ...
- Big Pharma nixes new drugs despite impending 'antibiotic apocalypse'on September 14, 2019 at 7:44 am
At a time when health officials are calling for mass demonstrations in favor of new antibiotics, drug companies have stopped making them altogether. Their sole reason, according to a new report: ...
- Bacteria developing new ways to resist antibiotics, doctors warnon September 10, 2019 at 4:07 pm
Over the last decade scientists in the UK studying samples from patients have identified 19 new mechanisms of antibiotic resistance. The changes in bacteria are driven by genetics and mean they become ...
- Northern Antibiotics working on a new molecule to fight antibiotic-resistant bacteriaon August 21, 2019 at 3:32 am
Finnish company Northern Antibiotics is working on a new antibiotic molecule, a derivative of polymyxin, that has significant potential to become one of the few last-resort weapons against bacteria ...
- Researchers examine how superbug fights last-resort antibioticson August 13, 2019 at 7:41 am
Antibiotic resistance is one of the biggest threats to global health, food security, and development today. A new study shows how superbugs adapt to combat 'last-resort antibiotics'. Researchers at ...
via Bing News